Cargando…
Plasmodium falciparum cGMP-Dependent Protein Kinase – A Novel Chemotherapeutic Target
The primary effector of cGMP signaling in Plasmodium is the cGMP-dependent protein kinase (PKG). Work in human-infective Plasmodium falciparum and rodent-infective Plasmodium berghei has provided biological validation of P. falciparum PKG (PfPKG) as a drug target for treating and/or protecting again...
Autores principales: | Rotella, David, Siekierka, John, Bhanot, Purnima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886688/ https://www.ncbi.nlm.nih.gov/pubmed/33613463 http://dx.doi.org/10.3389/fmicb.2020.610408 |
Ejemplares similares
-
Spatiotemporal and Functional Characterisation of the Plasmodium falciparum cGMP-Dependent Protein Kinase
por: Hopp, Christine S., et al.
Publicado: (2012) -
Crystal structures of the carboxyl cGMP binding domain of plasmodium falciparum cGMP-dependent protein kinase reveals a novel salt bridge crucial for activation
por: Kim, Jeong Joo, et al.
Publicado: (2013) -
Crystal Structures of the Carboxyl cGMP Binding Domain of the Plasmodium falciparum cGMP-dependent Protein Kinase Reveal a Novel Capping Triad Crucial for Merozoite Egress
por: Kim, Jeong Joo, et al.
Publicado: (2015) -
Targeting the Malaria Parasite cGMP-Dependent Protein Kinase to Develop New Drugs
por: Baker, David A., et al.
Publicado: (2020) -
The role of a parasite-specific D-site in activation of Plasmodium falciparum cGMP-dependent protein kinase
por: Franz, Eugen, et al.
Publicado: (2015)